Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled pre-prandial human insulin (AERx iDMS) plus metformin versus rosiglitazone plus metformin in type 2 diabetes
2006-000796-15Phase 3Terminated
- Sponsor
- Novo Nordisk
- Start
- Jul 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Change in HbA1c from baseline to 26 weeks. Started Jul 2006; status: terminated.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-000796-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000796-15.